Medicure Q2 FY26 net loss widens to C$ 1.4 million; revenue rises to C$ 7.4 million

Reuters2026/08/14 21:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medicure posted IFRS net loss of CAD 1.4 million, or CAD 0.14 a share, widening from CAD 786,000, or CAD 0.08.
Revenue rose 11.4% to CAD 7.4 million, led by Pharmacy Business Segment net revenue of CAD 5.9 million.
ZYPITAMAG revenue climbed 23.5% to CAD 2.1 million; AGGRASTAT revenue dropped 61.1% to CAD 661,000.
Adjusted EBITDA swung to a gain of CAD 172,000 from a loss of CAD 28,000, while R&D spending eased to CAD 608,000.
Unrestricted cash totaled CAD 1.8 million at June 30, down from CAD 3.8 million at Dec. 31.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicure Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608141700ACCESSWRNAPR_____1207579) on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Medicure Q2 FY26 net loss widens to C$ 1.4 million; revenue rises to C$ 7.4 million

You may also like

Crypto prices